SIGN UP
LOG IN
R
RGLS
Regulus Therapeu
7.85
-0.13-1.63%After Hours: 7.83 -0.02 -0.25%19:58 05/01 EDT
OPEN/PREV CLOSE7.84/7.98
TODAY RANGE7.77-7.95
VOL5.67M
MARKET CAP520.01M
52 WEEK RANGE0.8301-8.20
AVG VOL (3M)1.81M
% TURNOVER8.57%
TURNOVER--
P/E (TTM)-9.5418
% RANGE2.19%
EPS(TTM)-0.8227
P/E(FORWARD)-7.5845
P/B6.73
BVPS1.167
DIVIDEND--
P/S4.911
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP508.66M
SHARES OUTSTANDING66.24M
NEXT EARNINGS05/07-05/12
FREE FLOAT64.80M
LOT SIZE1
EX-DIV DATE06/29/2022
News
Press Releases
Financial Reports
Profile
TipRanks·12h ago
Biotech Alert: Searches spiking for these stocks today
Seeking Alpha·15h ago
Regulus CVR may be worth $3-$4 a share in Novartis deal - analyst
TipRanks·16h ago
Largest borrow rate increases among liquid names
Reuters·21h ago
U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics
TipRanks·1d ago
Regulus downgraded to Perform from Outperform at Oppenheimer
Seeking Alpha·1d ago
Regulus Therapeutics Acquisition By Novartis Due To Key Farabursen Advancements
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.